Premium
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alfero... AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alferon N Injection for a category of STD infection. Clinical trials of Ampligen include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer and triple negative metastatic breast cancer. The company is also advancing Ampligen as a potential treatment for COVID-19. FDA has authorized the first human trial assessing the safety and effectiveness of Ampligen in combination with interferon alfa-2b, in cancer patients with COVID-19. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0116 | 9.28 | 0.125 | 0.1399 | 0.1127 | 848388 | 0.12782137 | CS |
| 4 | -0.0234 | -14.625 | 0.16 | 0.16 | 0.1105 | 1645124 | 0.13962741 | CS |
| 12 | -0.0763 | -35.8384217943 | 0.2129 | 0.254 | 0.1105 | 1073799 | 0.16551365 | CS |
| 26 | -0.1824 | -57.1786833856 | 0.319 | 0.3392 | 0.1105 | 716979 | 0.18953464 | CS |
| 52 | -0.2534 | -64.9743589744 | 0.39 | 0.62 | 0.1105 | 488510 | 0.24970694 | CS |
| 156 | -0.5834 | -81.0277777778 | 0.72 | 1.38 | 0.1105 | 293771 | 0.47393689 | CS |
| 260 | -3.3634 | -96.0971428571 | 3.5 | 8.75 | 0.1105 | 1176062 | 2.59530646 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 20,88 (8,58%) | 139,35M |
| SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 6,69 (-1,47%) | 121,41M |
| MSTUT Rex 2X Long MSTR Daily Target ETF | US$ 6,0701 (-11,51%) | 90,17M |
| XLFFinancial Select Sector | US$ 49,12 (-0,53%) | 85,46M |
| SPYSPDR S&P 500 | US$ 575,92 (0,56%) | 80,19M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
